Canine leishmaniasis: Epidemiological risk and the experimental model

Trends in Parasitology

Volumn 18, Issue 9, 2002, Pages 399-405

  Moreno, Javier ^a   Alvar, Jorge ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Red de Investigación de Centros de Enfermedades Tropicales RICET Madrid   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; LEISHMANIA VACCINE; REAGENT;

BIOLOGICAL MONITORING; DOG; DOMESTIC ANIMAL; EXPERIMENTAL INFECTION; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIASIS; NONHUMAN; PARASITE IMMUNITY; PARASITE TRANSMISSION; PROMASTIGOTE; PUBLIC HEALTH; REVIEW; RISK FACTOR; VACCINE PRODUCTION; VISCERAL LEISHMANIASIS; ZOONOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; FEMALE; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; PROTOZOAN VACCINES;

ANIMALIA; CANIS FAMILIARIS; CANIS LUPUS; LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI CHAGASI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MYCOBACTERIUM BOVIS BCG; PROTOZOA;

EID: 0036744994     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(02)02347-4     Document Type: Review

References (71)

1. Baneth G., et al. Emergence of visceral leishmaniasis in central Israel. Am. J. Trop. Med. Hyg. 59:1998;722-725.
2. Gaskin A.A., et al. Visceral leishmaniasis in a New York foxhound kennel. J. Vet. Intern. Med. 16:2002;34-44.
3. Owens S.D., et al. Transmission of visceral leishmaniasis through blood transfusions from infected English foxhounds to anemic dogs. J. Am. Vet. Med. Assoc. 219:2001;1076-1083.
4. Cruz I., et al. Leishmania in discarded syringes from intravenous drug users. Lancet. 359:2002;1124-1125.
5. Alvar, J. (2001) Las Leishmaniasis: De la Biología al Control Laboratorios Intervet S.A. Salamanca
6. Zerpa O., et al. Canine visceral leishmaniasis on Margarita Island (Nueva Esparta, Venezuela). Trans. R. Soc. Trop. Med. Hyg. 94:2000;484-487.
7. Ashford D.A., et al. Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am. J. Trop. Med. Hyg. 59:1998;53-57.
8. Amela C., et al. Epidemiology of canine leishmaniasis in the Madrid region, Spain. Eur. J. Epidemiol. 11:1995;157-161.
9. Abranches P., et al. Canine leishmaniasis: pathological and ecological factors influencing transmission of infection. J. Parasitol. 77:1991;557-561.
10. Paranhos-Silva M., et al. Cohort study on canine emigration and Leishmania infection in an endemic area for American visceral leishmaniasis. Implications for the disease control. Acta Trop. 69:1998;75-83.
11. Dye C. The logic of visceral leishmaniasis control. Am. J. Trop. Med. Hyg. 55:1996;125-130.
12. Berrahal F., et al. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am. J. Trop. Med. Hyg. 55:1996;273-277.
13. Solano-Gallego L., et al. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J. Clin. Microbiol. 39:2001;560-563.
14. Molina R., et al. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans. R. Soc. Trop. Med. Hyg. 88:1994;491-493.
15. Travi B.L., et al. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sandflies. Am. J. Trop. Med. Hyg. 64:2001;119-124.
16. Cardoso L., et al. Use of leishmanin skin test in the detection of canine Leishmania-specific cellular immunity. Vet. Parasitol. 79:1998;213-220.
17. Cabral M., et al. Demonstration of Leishmania specific cell-mediated and humoral immunity in asymptomatic dogs. Parasite Immunol. 14:1992;531-539.
18. Semiao-Santos S.J., et al. Evora district as a new focus for canine leishmaniasis in Portugal. Parasitol. Res. 81:1995;235-239.
19. Fisa R., et al. Epidemiology of canine leishmaniosis in Catalonia (Spain): the example of the Priorat focus. Vet. Parasitol. 83:1999;87-97.
20. Pinelli E., et al. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62:1994;229-235.
21. Badaro R., et al. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154:1986;1000-1011.
22. Solano-Gallego L., et al. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Vet. Parasitol. 90:2000;37-45.
23. Moreno J., et al. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Vet. Immunol. Immunopathol. 71:1999;181-195.
24. Guarga J.L., et al. Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells. Res. Vet. Sci. 69:2000;249-253.
25. Molina R., et al. Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus. Am. J. Trop. Med. Hyg. 60:1999;51-53.
26. Alvar J., et al. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann. Trop. Med. Parasitol. 88:1994;371-378.
27. Guarga J.L., et al. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 88:2002;13-20.
28. Shao Q.F. Surveillance of kala-azar following preliminary eradication. Zhonghua Liu Xing Bing Xue Za Zhi. 3:1982;35-37.
29. Palatnik-de-Sousa C.B., et al. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am. J. Trop. Med. Hyg. 65:2001;510-517.
30. Gradoni L., et al. Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy. Trans. R. Soc. Trop. Med. Hyg. 82:1988;568-571.
31. Costa C.H., et al. Is the household dog a risk factor for American visceral leishmaniasis in Brazil? Trans. R. Soc. Trop. Med. Hyg. 93:1999;464.
32. Oliveira C.L., et al. Spatial distribution of human and canine visceral leishmaniasis in Belo Horizonte, Minas Gerais State, Brasil, 1994-1997. Cad. Saude Publica Rio de Janeiro. 17:2001;1231-1239.
33. Killick-Kendrick R., et al. Protection of dogs from bites of phlebotomine sandflies by deltamethrin collars for control of canine leishmaniasis. Med. Vet. Entomol. 11:1997;105-111.
34. Maroli M., et al. Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy. Med. Vet. Entomol. 15:2001;358-363.
35. Peters W., Killick-Kendrick R. The Leishmaniasis in Biology and Medicine. I-II:1987;Academic Press.
36. Hommel M., et al. Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann. Trop. Med. Parasitol. 89:(Suppl. 1):1995;55-73.
37. Solbach W., Laskay T. The host response to Leishmania infection. Adv. Immunol. 74:2000;275-317.
38. Cobbold S., Metcalfe S. Monoclonal antibodies that define homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens. 43:1994;137-154.
39. Willians D.L. Studies on canine leucocyte antigens: a significant advance in canine immunology. Vet. J. 153:1997;31-39.
40. Rabanal R.M., et al. Immunohistochemical detection of canine leucocyte antigens by specific monoclonal antibodies in canine normal tissue. Vet. Immunol. Immunopathol. 47:1995;13-23.
41. Weiss D.J. Evaluation of monoclonal antibodies for identification of subpopulations of myeloid cells in bone marrow obtained from dogs. Am. J. Vet. Res. 62:2001;1229-1233.
42. Bourdoiseau G., et al. Lymphocyte subset abnormalities in canine leishmaniasis. Vet. Immunol. Immunopathol. 56:1997;345-351.
43. Sinke J.D. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Vet. Immunol. Immunopathol. 57:1997;13-23.
44. Devos K., et al. Cloning and expression of the canine interferon-gamma gene. J. Interferon Res. 12:1992;95-102.
45. Knapp D.W., et al. Cloning of the canine interleukin-2-encoding cDNA. Gene. 159:1995;281-282.
46. Van der Kaaij S.Y., et al. Molecular cloning and sequencing of the cDNA for dog interleukin-4. Immunogenetics. 49:1999;143-144.
47. Argyle D.J., et al. Cloning, sequencing, and characterization of dog interleukin-18. Immunogenetics. 49:1999;541-543.
48. Pinelli E., et al. Detection of canine cytokine gene expression by reverse transcription polymerase chain reaction. Vet. Immunol. Immunopathol. 69:1999;121-126.
49. Quinnell R.J., et al. Tissue cytokine responses in canine visceral leishmaniasis. J. Infect. Dis. 183:2001;1421-1424.
50. Chamizo C., et al. Semi-quantitative analysis of multiple cytokines in canine peripheral blood mononuclear cells by a single tube RT-PCR. Vet. Immunol. Immunopathol. 83:2001;191-202.
51. Nieto C.G., et al. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis. Vet. Immunol. Immunopathol. 67:1999;117-130.
52. Rhalem A., et al. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. Vet. Parasitol. 81:1999;173-184.
53. Riera C., et al. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Vet. Parasitol. 84:1999;33-47.
54. Campino L., et al. Infectivity of promastigotes and amastigotes of Leishmania infantum in a canine model for leishmaniasis. Vet. Parasitol. 92:2000;269-275.
55. Killick-Kendrick R., et al. A laboratory model of canine leishmaniasis: the inoculation of dogs with Leishmania infantum promastigotes from midguts of experimentally infected phlebotomine sandflies. Parasite. 1:1994;311-318.
56. Leandro C., et al. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniasis. Vet. Immunol. Immunopathol. 79:2001;273-284.
57. Handman E. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 14:2001;229-243.
58. Dunan S., et al. Vaccination trial against canine visceral leishmaniasis. Parasite Immunol. 11:1989;397-402.
59. Monjour L., et al. Vaccination and treatment trials against murine leishmaniasis with semi-purified Leishmania antigens. Trans. R. Soc. Trop. Med. Hyg. 82:1988;412-415.
60. Mayrink W., et al. Phases I and II open clinical trials of a vaccine against Leishmania chagasi infection in dogs. Mem. Inst. Oswaldo Cruz. 91:1996;695-697.
61. Mohebali M. Vaccine trial against canine visceral leishmaniasis in the Islamic Republic of Iran. Rev Santé Mediterranée Orientale. 4:1998;234-238.
62. Lasri S., et al. Immune response in vaccinated dogs with autoclaved Leishmania major promastigotes. Vet. Res. 30:1999;441-449.
63. Panaro M.A., et al. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. Comp. Immunol. Microbiol. Infect. Dis. 24:2001;187-195.
64. Gradoni L. An update on antileishmanial vaccine candidates and prospects for canine Leishmania vaccine. Vet. Parasitol. 100:2001;87-103.
65. da Silva V.O., et al. A Phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Gonçalo do Amaranto, RN). Vaccine. 19:2001;1082-1092.
66. Abranches P., et al. An experimental model for canine visceral leishmaniasis. Parasite Immunol. 13:1991;537-550.
67. Oliveira G.G.S., et al. The subclinical form of experimental visceral leishmaniasis in dogs. Mem. Inst. Oswaldo Cruz. 88:1993;243-248.
68. Binhazim A.A., et al. Determination of virulence and pathogenesis of a canine strain of Leishmania infantum in hamster and dogs. Am. J. Vet. Res. 54:1993;113-121.
69. Martinez-Moreno A., et al. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. Vet. Immunol. Immunopathol. 48:1995;209-220.
70. Santos-Gomes G.M., et al. Canine experimental infection: intradermal inoculation of Leishmania infantum promastigotes. Mem. Inst. Oswaldo Cruz. 95:2000;193-198.
71. Carrera L., et al. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. Exp. Parasitol. 82:1996;139-146.